Original articleSynthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects
-
Add time:09/01/2019 Source:sciencedirect.com
A new Mannich base series of piperazine linked berberine analogues was furnished in this study to screen the antioxidant and anticancer potential of the resultant analogues. Alkoxy group at a C-9 position of berberine was converted to hydroxyl functionality to enhance the ability of final scaffolds binding to the target of drug action mainly through hydrophobic effect, conjugation effect, whereas Mannich base functionality was introduced on the C-12 position of berberine. Scaffolds were investigated for their free radical scavenging antioxidant potential in FRAP and DPPH assay, whereas tested to check their Fe+3 reducing power in ABTS assay. The radical scavenging potential of the final derivatives 4a–j was found excellent with IC50s, <13 μg/mL and < 8 μg/mL in DPPH and ABTS assay, respectively, whereas some analogues showed significant Fe+3 reducing power with absorption at around 2 nm in the FRAP assay. Anticancer effects of titled compounds were inspected against cervical cancer cell line Hela and Caski adapting SRB assay, in which analogues 4a–j presented <6 μg/mL of IC50s, and >30 of therapeutic indices, thus exerting low cytotoxic values against Malin–Darby canine kidney (MDCK) cell lines at CC50s >125 μg/mL. Hence, from the bioassay outcomes it can be stated that these analogues are dual active agents as the scavengers of reactive oxygen species and inhibitors of the cancerous cells as compounds with halogen functional group have overall good pharmacological potential in assays studied in this research. Correct structure of the final compounds was adequately confirmed on the basis of FT-IR and 1H NMR as well as elemental analyses.
We also recommend Trading Suppliers and Manufacturers of N-(3-Trifluoromethylphenyl)piperazine (cas 15532-75-9). Pls Click Website Link as below: cas 15532-75-9 suppliers
Prev:MDMA-like behavioral effects of N-substituted piperazines in the mouse
Next:Rapid communicationStimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol and mesulergine☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Rapid communicationStimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol and mesulergine☆09/02/2019
- MDMA-like behavioral effects of N-substituted piperazines in the mouse08/31/2019
- Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl) piperazine08/30/2019
- Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment08/29/2019
- Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models08/28/2019
- Mise au pointLa 1-benzylpipérazine (BZP) et la 1-(3-trifluorométhylphényl)pipérazine (TFMPP) : émergence de deux substances donnant lieu à un usage abusif1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): Emergence of two agents which lead to misuse08/27/2019
- Development of simultaneous gas chromatography–mass spectrometric and liquid chromatography–electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine08/26/2019
- ReviewPiperazine compounds as drugs of abuse08/25/2019
- ORIGINAL ARTICLEDevelopment of a targeted GC/MS screening method and validation of an HPLC/DAD quantification method for piperazines–amphetamines mixtures in seized material08/24/2019


